• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    CareCloud Emerges as a Top Gainer in Russell Microcap Index for Q2 2025 with 70% Quarterly Increase

    7/10/25 8:00:00 AM ET
    $CCLD
    Computer Software: Prepackaged Software
    Technology
    Get the next $CCLD alert in real time by email

    SOMERSET, N.J., July 10, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)) ("CareCloud" or the "Company"), a leader in AI-powered healthcare technology and revenue cycle management solutions, today announced that its common stock rose approximately 70% during the second quarter of 2025, making it among the top gainers in the Russell Microcap® Index for the period.

    The Company was officially added to the Russell Microcap Index effective June 30, 2025, following the annual reconstitution of the Russell indexes. The inclusion and strong performance underscore CareCloud's growing visibility and investor confidence in its strategic direction.

    "Our performance this quarter reflects growing investor confidence in our strategic direction, particularly as we accelerate AI innovation, re-engage in targeted acquisitions, and enhance our capital structure," said Stephen Snyder, Co-CEO of CareCloud. "With a strengthened balance sheet, an expanding public float, and a renewed focus on delivering intelligent health solutions, we believe CareCloud is well positioned for long-term growth."

    First Half 2025 Highlights:

    • Launched its new AI Center of Excellence
    • Resumed M&A activity targeting high-potential verticals
    • Completed conversion of 3.5 million Series A Preferred shares into Common Stock
    • Ended the quarter with over $10 million in cash
    • Added to the Russell Microcap Index

    The Company believes that these developments reflect CareCloud's disciplined execution and position the Company for continued momentum into the second half of 2025.

    About CareCloud

    CareCloud, Inc. is a leading provider of healthcare technology solutions for medical practices and health systems. CareCloud's comprehensive suite of revenue cycle, practice management, and patient engagement solutions is supported by emerging AI technologies to improve clinical and financial outcomes.

    Follow CareCloud on LinkedIn, X and Facebook.

    For additional information, please visit our website at carecloud.com. To listen to video presentations by CareCloud's management team, read recent press releases and view the latest investor presentation, please visit ir.carecloud.com.

    Disclaimer

    This press release is for information purposes only and does not constitute an offer to sell or solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.

    Forward-Looking Statements

    This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as "may," "might," "will," "shall," "should," "could", "intends," "expects," "plans," "goals," "projects," "anticipates," "believes," "seeks," "estimates," "predicts," "possible," "potential," "target," or "continue" or the negative of these terms or other comparable terminology.

    Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, and the expected results from the integration of our acquisitions. Past operational or stock price performance is not an indication of future performance.

    These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry's) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company's ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies' products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled "Risk Factors" in the Company's filings with the Securities and Exchange Commission.

    The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.

    SOURCE: CareCloud

    Company Contact: 

    Norman Roth 

    Interim Chief Financial Officer and Corporate Controller 

    CareCloud, Inc.

    [email protected] 

    Investor Contact:

    Stephen Snyder 

    Co-Chief Executive Officer 

    CareCloud, Inc. 

    [email protected] 



    Primary Logo

    Get the next $CCLD alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $CCLD

    DatePrice TargetRatingAnalyst
    11/13/2024$5.00 → $3.50Buy → Neutral
    ROTH MKM
    More analyst ratings

    $CCLD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • CareCloud Launches AI-Driven, Fully Integrated Dermatology EHR to Streamline Workflows and Enhance Patient Care

      SOMERSET, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)) ("CareCloud" or the "Company"), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, today announced the launch of its fully integrated, AI-driven dermatology EHR, designed to streamline clinical workflows and collections, while enhancing patient engagement and improving financial outcomes for dermatology practices. "Our fully integrated, AI-driven dermatology EHR empowers practices with modern tools that are developed for the unique practice workflows and needs of busy dermatology groups, and designed to enhance their efficiency, accuracy,

      7/17/25 8:00:00 AM ET
      $CCLD
      Computer Software: Prepackaged Software
      Technology
    • CareCloud to Announce Second Quarter 2025 Results on August 5, 2025

      SOMERSET, N.J., July 16, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)) ("CareCloud" or the "Company"), a leader in AI-powered healthcare technology and revenue cycle management solutions for medical practices and health systems nationwide, will release its financial results for the second quarter ended June 30, 2025 before the market opens on Tuesday, August 5, 2025. The Company will follow with a conference call for investors at 8:30 a.m. Eastern Time. The live webcast of the conference call and related presentation slides can be accessed at ir.carecloud.com/events. An audio-only option is available by dialing 201-389-0920 and referencing "CareCloud, Inc. Second Quarter

      7/16/25 8:00:00 AM ET
      $CCLD
      Computer Software: Prepackaged Software
      Technology
    • CareCloud Emerges as a Top Gainer in Russell Microcap Index for Q2 2025 with 70% Quarterly Increase

      SOMERSET, N.J., July 10, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)) ("CareCloud" or the "Company"), a leader in AI-powered healthcare technology and revenue cycle management solutions, today announced that its common stock rose approximately 70% during the second quarter of 2025, making it among the top gainers in the Russell Microcap® Index for the period. The Company was officially added to the Russell Microcap Index effective June 30, 2025, following the annual reconstitution of the Russell indexes. The inclusion and strong performance underscore CareCloud's growing visibility and investor confidence in its strategic direction. "Our performance this quarter reflect

      7/10/25 8:00:00 AM ET
      $CCLD
      Computer Software: Prepackaged Software
      Technology

    $CCLD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Daly John N sold $31,650 worth of shares (15,000 units at $2.11), decreasing direct ownership by 20% to 61,750 units (SEC Form 4)

      4 - CareCloud, Inc. (0001582982) (Issuer)

      6/18/25 9:30:05 PM ET
      $CCLD
      Computer Software: Prepackaged Software
      Technology
    • Director Munter Cameron converted options into 7,500 shares, increasing direct ownership by 5% to 174,000 units (SEC Form 4)

      4 - CareCloud, Inc. (0001582982) (Issuer)

      2/11/25 9:30:10 PM ET
      $CCLD
      Computer Software: Prepackaged Software
      Technology
    • Director Busquet Anne converted options into 7,500 shares, increasing direct ownership by 3% to 266,388 units (SEC Form 4)

      4 - CareCloud, Inc. (0001582982) (Issuer)

      2/11/25 9:30:08 PM ET
      $CCLD
      Computer Software: Prepackaged Software
      Technology

    $CCLD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • CareCloud downgraded by ROTH MKM with a new price target

      ROTH MKM downgraded CareCloud from Buy to Neutral and set a new price target of $3.50 from $5.00 previously

      11/13/24 7:36:28 AM ET
      $CCLD
      Computer Software: Prepackaged Software
      Technology

    $CCLD
    SEC Filings

    See more
    • CareCloud Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - CareCloud, Inc. (0001582982) (Filer)

      7/2/25 8:05:16 AM ET
      $CCLD
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 8-K filed by CareCloud Inc.

      8-K - CareCloud, Inc. (0001582982) (Filer)

      5/28/25 8:00:53 AM ET
      $CCLD
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 10-Q filed by CareCloud Inc.

      10-Q - CareCloud, Inc. (0001582982) (Filer)

      5/6/25 4:30:53 PM ET
      $CCLD
      Computer Software: Prepackaged Software
      Technology

    $CCLD
    Leadership Updates

    Live Leadership Updates

    See more
    • CareCloud Announces Results from Annual Shareholders' Meeting

      Shareholders Re-Elect 3 Board Members, Approve the Compensation for the Company's Named Executives and Approve the Appointment of Public Accounting Firm SOMERSET, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO)), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that it held its 2025 Annual Shareholders' Meeting on May 27, 2025, during which shareholders re-elected Anne Busquet, Bill Korn and Lawrence Sharnak for another two-year term. Shareholders also voted to approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's 20

      5/28/25 8:05:00 AM ET
      $CCLD
      Computer Software: Prepackaged Software
      Technology
    • CareCloud Acquires RevNu Medical Management, Completing Second Acquisition in 31 Days

      SOMERSET, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO)), a leading provider of practice management, healthcare technology and AI-driven solutions to medical practices across the country, today announced the acquisition of RevNu Medical Management ("RevNu"), an emerging audiology-focused revenue cycle management ("RCM") company based in Westminster, California. "We've spent years building trusted relationships within the audiology community, and we couldn't be more excited to join forces with CareCloud," said Clay Gililland, founder of RevNu. "That experience has given us a deep understanding of the industry's needs—insights we're excited to

      4/2/25 9:00:00 AM ET
      $CCLD
      Computer Software: Prepackaged Software
      Technology
    • CareCloud Welcomes Justin Pierce as Chief Sales Officer

      SOMERSET, N.J., Dec. 04, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDP, CCLDO))), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced the appointment of Justin Pierce as its new chief sales officer (CSO). In this role, Pierce will be responsible for driving sustainable revenue growth and enhancing CareCloud's position in the rapidly evolving healthcare landscape. Pierce brings more than two decades of experience in the healthcare technology and services industry, having held leadership positions at Azalea Health, abeo, and Ventra Health. Throughout his career, he has consistently demonstrated his ability to forge

      12/4/23 9:30:00 AM ET
      $CCLD
      Computer Software: Prepackaged Software
      Technology

    $CCLD
    Financials

    Live finance-specific insights

    See more
    • CareCloud to Announce Second Quarter 2025 Results on August 5, 2025

      SOMERSET, N.J., July 16, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)) ("CareCloud" or the "Company"), a leader in AI-powered healthcare technology and revenue cycle management solutions for medical practices and health systems nationwide, will release its financial results for the second quarter ended June 30, 2025 before the market opens on Tuesday, August 5, 2025. The Company will follow with a conference call for investors at 8:30 a.m. Eastern Time. The live webcast of the conference call and related presentation slides can be accessed at ir.carecloud.com/events. An audio-only option is available by dialing 201-389-0920 and referencing "CareCloud, Inc. Second Quarter

      7/16/25 8:00:00 AM ET
      $CCLD
      Computer Software: Prepackaged Software
      Technology
    • CareCloud Named "Top Healthcare IT Pick for 2025" by Maxim Group; AI Initiative Recognized as Key Growth Driver

      SOMERSET, N.J., May 13, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)) ("CareCloud" or the "Company"), a leader in healthcare technology and generative AI solutions, today announced that Maxim Group, LLC ("Maxim Group"), a leading investment bank, securities and wealth management firm, has selected CareCloud as its "Top Healthcare IT Pick for 2025," citing the transformative potential of its artificial intelligence strategy, together with its strong financial results and renewed M&A activity. "Given its positive outlook and attractive valuation, CareCloud is positioned to be our top healthcare IT pick in 2025," said Allen Klee, CFA, Managing Director and Senior Equity Rese

      5/13/25 8:00:00 AM ET
      $CCLD
      Computer Software: Prepackaged Software
      Technology
    • CareCloud Delivers Growth and Strong Cash Flow in Q1 2025, Advances AI and Acquisition Strategy

      SOMERSET, N.J., May 06, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)), a leader in healthcare technology and generative AI solutions, today announced strong financial results for the three months ended March 31, 2025. CareCloud's strategic execution, AI-driven innovation, and disciplined financial management have fueled a transformational turnaround, positioning the Company for sustained profitability and long-term growth. Management will discuss these results and the Company's 2025 growth strategies in a live conference call today at 8:30 a.m. ET. First Quarter 2025 Financial Highlights: Revenue of $27.6 million, compared to $26.0 million in Q1 2024, an increase of 6% y

      5/6/25 7:00:00 AM ET
      $CCLD
      Computer Software: Prepackaged Software
      Technology